Kiliç E - Search Results

1

Prognostic parameters in uveal melanoma and their association with BAP1 expression.

van Essen TH, van Pelt SI, Versluis M, Bronkhorst IH, van Duinen SG, Marinkovic M, Kroes WG, Ruivenkamp CA, Shukla S, de Klein A, Kiliç E, Harbour JW, Luyten GP, van der Velden PA, Verdijk RM, Jager MJ. van Essen TH, et al. Among authors: kilic e. Br J Ophthalmol. 2014 Dec;98(12):1738-43. doi: 10.1136/bjophthalmol-2014-305047. Epub 2014 Aug 21. Br J Ophthalmol. 2014. PMID: 25147369 Free PMC article.

2

Dose fractionation effects in primary and metastatic human uveal melanoma cell lines.

van den Aardweg GJ, Kiliç E, de Klein A, Luyten GP. van den Aardweg GJ, et al. Among authors: kilic e. Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4660-4. doi: 10.1167/iovs.03-0151. Invest Ophthalmol Vis Sci. 2003. PMID: 14578382 Free article.

3

The RAS-BRAF kinase pathway is not involved in uveal melanoma.

Kiliç E, Brüggenwirth HT, Verbiest MM, Zwarthoff EC, Mooy NM, Luyten GP, de Klein A. Kiliç E, et al. Melanoma Res. 2004 Jun;14(3):203-5. doi: 10.1097/01.cmr.0000130006.46885.a0. Melanoma Res. 2004. PMID: 15179189

4

Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients.

Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A. Kilic E, et al. Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2253-7. doi: 10.1167/iovs.04-1460. Invest Ophthalmol Vis Sci. 2005. PMID: 15980208

5

Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy.

Kilic E, Stijnen T, de Jong PT, Mooy CM, Eijkenboom WM, Ringens PJ, Luyten GP. Kilic E, et al. Arch Ophthalmol. 2005 Oct;123(10):1363-7. doi: 10.1001/archopht.123.10.1363. Arch Ophthalmol. 2005. PMID: 16219727

6

Clinical and cytogenetic analyses in uveal melanoma.

Kilic E, van Gils W, Lodder E, Beverloo HB, van Til ME, Mooy CM, Paridaens D, de Klein A, Luyten GP. Kilic E, et al. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3703-7. doi: 10.1167/iovs.06-0101. Invest Ophthalmol Vis Sci. 2006. PMID: 16936076

7

Expression of APITD1 is not related to copy number changes of chromosomal region 1p36 or the prognosis of uveal melanoma.

van Gils W, Mensink HW, Kilic E, Vaarwater J, Verbiest MM, Paridaens D, Luyten GP, de Klein A, Brüggenwirth HT. van Gils W, et al. Among authors: kilic e. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4919-23. doi: 10.1167/iovs.07-0061. Invest Ophthalmol Vis Sci. 2007. PMID: 17962439

8

Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.

Maat W, Kilic E, Luyten GP, de Klein A, Jager MJ, Gruis NA, Van der Velden PA. Maat W, et al. Among authors: kilic e. Invest Ophthalmol Vis Sci. 2008 Jan;49(1):23-7. doi: 10.1167/iovs.07-0722. Invest Ophthalmol Vis Sci. 2008. PMID: 18172070

9

Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.

van Gils W, Kilic E, Brüggenwirth HT, Vaarwater J, Verbiest MM, Beverloo B, van Til-Berg ME, Paridaens D, Luyten GP, de Klein A. van Gils W, et al. Among authors: kilic e. Melanoma Res. 2008 Feb;18(1):10-5. doi: 10.1097/CMR.0b013e3282f1d4d9. Melanoma Res. 2008. PMID: 18227702

10

Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.

Mensink HW, Kiliç E, Vaarwater J, Douben H, Paridaens D, de Klein A. Mensink HW, et al. Among authors: kilic e. Cancer Genet Cytogenet. 2008 Mar;181(2):108-11. doi: 10.1016/j.cancergencyto.2007.12.001. Cancer Genet Cytogenet. 2008. PMID: 18295662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

804 results

Search Page